Feedback / Questions
isomyosamine (MYMD1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20210727005570/en/MyMD-Pharmaceuticals%E2%80%99-Lead-Compound-MYMD-1-Shows-Commonality-in-Comparative-Study-with-FDA-Approved-Anti-Inflammatory-and-Anti-Autoimmune-Drugs-Used-for-Arthritis-Colitis-and-Dermatitis
Jul 27, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next